Galectin

Results: 15



#Item
1Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers Jerome Mauris1, Flavio Mantelli1¤a, Ashley M. Woodward1, Ziyhi Cao2, Caro

Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers Jerome Mauris1, Flavio Mantelli1¤a, Ashley M. Woodward1, Ziyhi Cao2, Caro

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
2Archives of Biochemistry and Biophysics Vol. 383, No. 2, November 15, pp. 157–170, 2000 doi:abbi, available online at http://www.idealibrary.com on Differences in Zero-Force and Force-Driven Kinetics

Archives of Biochemistry and Biophysics Vol. 383, No. 2, November 15, pp. 157–170, 2000 doi:abbi, available online at http://www.idealibrary.com on Differences in Zero-Force and Force-Driven Kinetics

Add to Reading List

Source URL: www.biophysik.physik.uni-muenchen.de

Language: English - Date: 2015-11-10 10:48:39
3Classification and Motif Extraction of Glycans in Bloods Yoshiyuki Hizukuri1 Yoshihiro Yamanishi1 Osamu Nakamura2

Classification and Motif Extraction of Glycans in Bloods Yoshiyuki Hizukuri1 Yoshihiro Yamanishi1 Osamu Nakamura2

Add to Reading List

Source URL: www.jsbi.org

Language: English - Date: 2005-01-18 03:44:17
4Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and its Novel Galectin-3 inhibitor in Development for Idiopathic Pulmonary Fibrosis (NEW YORK and COPENHAGEN – November 3, Bri

Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and its Novel Galectin-3 inhibitor in Development for Idiopathic Pulmonary Fibrosis (NEW YORK and COPENHAGEN – November 3, Bri

Add to Reading List

Source URL: sunstone.eu

- Date: 2014-11-03 07:57:22
    5Synthetic inhibitors of galectin-1 and -3 sel... [Anticancer Resdi 1 Display Settings:

    Synthetic inhibitors of galectin-1 and -3 sel... [Anticancer Resdi 1 Display Settings:

    Add to Reading List

    Source URL: www.cinbo.org

    Language: English - Date: 2012-12-21 09:31:05
      6Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment

      Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment

      Add to Reading List

      Source URL: www.nature.com

      Language: English - Date: 2010-11-18 09:32:27
      7Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death

      Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death

      Add to Reading List

      Source URL: www.nature.com

      Language: English - Date: 2010-02-04 08:58:19
      8A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells

      A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells

      Add to Reading List

      Source URL: www.nature.com

      Language: English - Date: 2012-01-12 05:57:43
      9The glycan-binding protein galectin-1 controls survival of epithelial cells along the crypt-villus axis of small intestine

      The glycan-binding protein galectin-1 controls survival of epithelial cells along the crypt-villus axis of small intestine

      Add to Reading List

      Source URL: www.nature.com

      Language: English
      10(Significantly Regulated) Listing of U.S. Industries for Filing Year 2014 Company Galectin Therapeutics Inc. Galena Biopharma, Inc. Gelstat Corporation Geltech Solutions, Inc.

      (Significantly Regulated) Listing of U.S. Industries for Filing Year 2014 Company Galectin Therapeutics Inc. Galena Biopharma, Inc. Gelstat Corporation Geltech Solutions, Inc.

      Add to Reading List

      Source URL: www.fda.gov

      Language: English